Subscribe to MDT Magazine News

Noveko International shrinks its Q2 losses on higher sales during H1N1 crisis

February 10, 2011 8:45 am | by The Associated Press | Comments

Noveko International Inc. (TSX:EKO) says the H1N1 flu crisis last year helped shrink its second-quarter net loss this year to $2.93 million.The maker of antimicrobial face masks cut its loss to three cents per share from seven cents or $5.01 million the year-earlier quarter.Noveko said sales of...

Research Team Honored for Innovative Science to Advance Cancer Research

February 10, 2011 6:33 am | by AACR | Comments

ORLANDO, Fla. - The Fifth Annual AACR Team Science Award will be given to a team of internationally renowned molecular biologists, epidemiologists, biostatisticians and clinicians from Fred Hutchinson Cancer Research Center and University of Washington who have worked together on human...


UnitedHealth board declares 12.5-cent dividend

February 10, 2011 5:45 am | by The Associated Press | Comments

Health insurer UnitedHealth Group Inc. said Thursday that its board of directors approved a regular quarterly dividend of 12.5 cents.The dividend will be paid on March 21 to shareholders as of March 7.


UnitedHealth names Lawson to board

February 10, 2011 5:45 am | by The Associated Press | Comments

The former and CEO of Fidelity Investments has joined the board at UnitedHealth Group Inc., the company said Thursday.Prior to joining Fidelity in 2007, Rodger A. Lawson was vice chairman of Prudential Financial.Lawson will stand for re-election by shareholders at the 2011 annual meeting along...

CHAMPION Study Published in The Lancet

February 10, 2011 5:34 am | by Bio-Medicine.Org | Comments

ATLANTA, Feb. 10, 2011 /- The CHAMPION ( C ardioMEMS H eart Sensor A llows M onitoring of P ressure to I mprove O utcomes in N YHA Class III Patients) clinical trial was published online today in The Lancet . CHAMPION demonstrated a 30% reduction in the primary efficacy endpoint of heart...


New & #8216;Better By Nature & #8217; Detox Plan Promotes Health And Well-Being To Give Spring-time Feel Good Factor

February 10, 2011 4:32 am | by RealWire | Comments

"8 Weeks to a Better You" Optimum Health Plan combines detox and support for specific well-being issues using new synergistic homeopathic remediesBetter by Nature, the Stratford-On-Avon based health and well-being company, specialises in holistic homeopathic remedies based on creating...


Alexion buys IP from German biotech for infant disorder

February 10, 2011 3:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Alexion Pharmaceuticals Inc. acquired patents and assets for a possible therapy for a ultra-rare genetic disorder for $3 million in cash from Germany-based Orphatec Pharmaceuticals GmbH.


Functional Technologies Receives FDA "No Questions" Letter on GRAS Status of Hydrogen Sulphide-Reducing Yeast

February 10, 2011 2:45 am | by The Associated Press | Comments () —Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") today announced that the U.S. Food and Drug Administration (FDA) has reviewed, and issued a "no questions" letter in response to, the Generally Recognized as Safe (GRAS) notification for the...


Stereotaxis to Report Fourth Quarter and Full Year 2010 Financial Results and Conduct Conference Call on February 28, 2011

February 10, 2011 2:35 am | by Bio-Medicine.Org | Comments

ST. LOUIS, Feb. 10, 2011 /- Stereotaxis, Inc. (Nasdaq: STXS ) today announced that it will release financial results for the fourth quarter and full year ended December 31, 2010 on Monday, February 28, 2011 after the close of the U.S. financial markets. The Company will host a conference...


Covidien Receives FDA Approval for Fentanyl Transdermal System Patch

February 10, 2011 2:33 am | by Covidien | Comments

ST. LOUIS, Feb 10, 2011 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that Mallinckrodt Inc., a Covidien company, has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for...


Tegal sells DRIE assets to SPTS

February 9, 2011 11:37 pm | by I-Micronews | Comments

Tegal?s focus now exclusively on Green Energy.

U.S. Postal Inspection Service Awards AED Contract to Cardiac Science

February 9, 2011 11:34 pm | by Bio-Medicine.Org | Comments

BOTHELL, Wash., Feb. 10, 2011 /- Cardiac Science Corporation , a global leader in automated external defibrillator ( AED ) and diagnostic cardiac monitoring devices, has been awarded a contract to deploy Powerheart® AEDs at U.S. Postal Inspection Service sites across the nation. The...


Class I Medical Device Recall: Arstasis One Access System

February 9, 2011 8:39 pm | by U.S. Food & Drug Administration | Comments

The Arstasis One Access System is used in patients undergoing diagnostic femoral artery (upper leg) catheterization procedures. It provides device access into the vascular system. This product also helps to stop the artery from bleeding when used in...

AMAG iron replacement drug's Canadian approval stalled

February 9, 2011 8:38 pm | by Mass High Tech: The Journal of New England Technology | Comments

Health Canada has stalled a new drug submission from AMAG Pharmaceuticals Inc. with a notice of non-compliance for its Feraheme injection, intended to treat iron deficiency anemia in adult chronic kidney disease patients.

Sand 9 appoints Greg Waters to Board of Directors

February 9, 2011 8:38 pm | by I-Micronews | Comments

Senior Skyworks Executive Joins Board to Help Guide the Company in its Transition from Development to Commercial Production


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.